Literature DB >> 20588184

Considerations in using US-based laboratory toxicity tables to evaluate laboratory toxicities among healthy malawian and Ugandan infants.

Irene R Lubega1, Mary Glenn Fowler, Philippa M Musoke, Ali Elbireer, Danstan Bagenda, George Kafulafula, Jeanne Ko, Linda Mipando, Mike Mubiru, Newton Kumwenda, Taha Taha, J Brooks Jackson, Laura Guay.   

Abstract

OBJECTIVES: To determine normal hematologic and selected blood chemistry values among healthy, full-term, non-HIV-exposed infants in Uganda and Malawi, and to determine the proportion of healthy babies with an apparent laboratory toxicity based on Division of AIDS toxicity tables.
DESIGN: This was a cross-sectional laboratory study of infants from birth to 6 months of age.
METHODS: Blood samples were collected from a total of 561 infants and analyzed according to age categories similar to those in the 2004 Division of AIDS toxicity tables. Select chemistry and hematology parameters were determined and values compared with those in the toxicity tables.
RESULTS: In the first 56 days of life, there were few graded toxicities except for neutropenia in 2 of 10 (20%) Ugandan and 13 of 45 (29%) Malawian infants at birth. After 7 days, about 20% of the infants in Uganda and Malawi would have been classified as having a neutropenia whereas 47% and 53% of those more than 2 months of age in Uganda and Malawi respectively, would have been reported as having an abnormal hemoglobin. Chemistry findings were not different from US norms.
CONCLUSIONS: These findings underscore the importance of establishing relevant local laboratory norms for infants.

Entities:  

Mesh:

Year:  2010        PMID: 20588184      PMCID: PMC3033212          DOI: 10.1097/QAI.0b013e3181db059d

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  17 in total

1.  Population-based hematologic and immunologic reference values for a healthy Ugandan population.

Authors:  Eric S Lugada; Jonathan Mermin; Frank Kaharuza; Elling Ulvestad; Willy Were; Nina Langeland; Birgitta Asjo; Sam Malamba; Robert Downing
Journal:  Clin Diagn Lab Immunol       Date:  2004-01

2.  Haematological and biochemical indices in young African children: in search of reference intervals.

Authors:  Llorenç Quintó; John J Aponte; Jahit Sacarlal; Mateu Espasa; Pedro Aide; Inacio Mandomando; Caterina Guinovart; Eusebio Macete; Margarita M Navia; Ricardo Thompson; Clara Menéndez; Pedro L Alonso
Journal:  Trop Med Int Health       Date:  2006-11       Impact factor: 2.622

3.  Effect of HIV-1 antiretroviral prophylaxis on hepatic and hematological parameters of African infants.

Authors:  Taha E Taha; Newton Kumwenda; Amanda Gibbons; Donald Hoover; Valentino Lema; Susan Fiscus; Joshua Mukiibi; George Liomba; Robin Broadhead
Journal:  AIDS       Date:  2002-04-12       Impact factor: 4.177

4.  Comparison of some haematological indices of Africans and Caucasians resident in the same Nigerian environment.

Authors:  N Nduka; C Aneke; S Maxwell-Owhochuku
Journal:  Haematologia (Budap)       Date:  1988

5.  The leucocyte picture in white, Bantu, coloured and Indian school children of 6-15 years as observed during the Pretoria nutrition status surveys of 1962-1965.

Authors:  M L Neser
Journal:  S Afr Med J       Date:  1968-05-04

6.  Some haematological parameters in Malawian neonates.

Authors:  J M Mukiibi; L A Mtimavalye; R Broadhead; E Mzula; W E Dzinyemba; R Merrick; C O Khoromana; G W Ching'ani
Journal:  East Afr Med J       Date:  1995-01

7.  Normal hematological values of the African neonate.

Authors:  A B Scott-Emuakpor; A A Okolo; J A Omene; S I Ukpe
Journal:  Blut       Date:  1985-07

8.  The costs associated with adverse event procedures for an international HIV clinical trial determined by activity-based costing.

Authors:  Victoria B Chou; Saad B Omer; Hamidah Hussain; Christine Mugasha; Maria Musisi; Francis Mmiro; Philippa Musoke; J Brooks Jackson; Laura A Guay
Journal:  J Acquir Immune Defic Syndr       Date:  2007-12-01       Impact factor: 3.731

9.  Are there gender and race differences in cellular immunity patterns over age in infected and uninfected children born to HIV-infected women?

Authors: 
Journal:  J Acquir Immune Defic Syndr       Date:  2003-08-15       Impact factor: 3.731

10.  Within and between race differences in lymphocyte, CD4+, CD8+ and neutrophil levels in HIV-uninfected children with or without HIV exposure in Europe and Uganda.

Authors:  Madeleine Bunders; Eric Lugada; Jonathan Mermin; Robert Downing; Willy Were; Claire Thorne; Marie-Louise Newell
Journal:  Ann Trop Paediatr       Date:  2006-09
View more
  8 in total

1.  Distribution of haematological and chemical pathology values among infants in Malawi and Uganda.

Authors:  Newton I Kumwenda; Tiwonge Khonje; Linda Mipando; Kondwani Nkanaunena; Pauline Katundu; Irene Lubega; Ali Elbireer; Steve Bolton; Danstan Bagenda; Michael Mubiru; Mary Glenn Fowler; Taha E Taha
Journal:  Paediatr Int Child Health       Date:  2012       Impact factor: 1.990

2.  Virologic and immunologic outcomes of HIV-infected Ugandan children randomized to lopinavir/ritonavir or nonnucleoside reverse transcriptase inhibitor therapy.

Authors:  Theodore D Ruel; Abel Kakuru; Gloria Ikilezi; Florence Mwangwa; Grant Dorsey; Philip J Rosenthal; Edwin Charlebois; Diane Havlir; Moses Kamya; Jane Achan
Journal:  J Acquir Immune Defic Syndr       Date:  2014-04-15       Impact factor: 3.731

3.  Feasibility and safety of ALVAC-HIV vCP1521 vaccine in HIV-exposed infants in Uganda: results from the first HIV vaccine trial in infants in Africa.

Authors:  Kenneth Kintu; Philip Andrew; Philippa Musoke; Paul Richardson; Brenda Asiimwe-Kateera; Teopista Nakyanzi; Lei Wang; Mary Glenn Fowler; Lynda Emel; San-San Ou; Lynn Baglyos; Sanjay Gurunathan; Sheryl Zwerski; Jay Brooks Jackson; Laura Guay
Journal:  J Acquir Immune Defic Syndr       Date:  2013-05-01       Impact factor: 3.731

4.  Lessons learnt from the first efficacy trial of a new infant tuberculosis vaccine since BCG.

Authors:  Michele Tameris; Helen McShane; J Bruce McClain; Bernard Landry; Stephen Lockhart; Angelique K K Luabeya; Hennie Geldenhuys; Jacqui Shea; Gregory Hussey; Linda van der Merwe; Marwou de Kock; Thomas Scriba; Robert Walker; Willem Hanekom; Mark Hatherill; Hassan Mahomed
Journal:  Tuberculosis (Edinb)       Date:  2013-02-12       Impact factor: 3.131

5.  Evaluation of locally established reference intervals for hematology and biochemistry parameters in Western Kenya.

Authors:  Collins Odhiambo; Boaz Oyaro; Richard Odipo; Fredrick Otieno; George Alemnji; John Williamson; Clement Zeh
Journal:  PLoS One       Date:  2015-04-13       Impact factor: 3.240

6.  Immunohaematological reference values for HIV-negative healthy adults in Botswana.

Authors:  Madisa Mine; Sikhulile Moyo; Penny Stevens; Kurt Michael; Vladimir Novitsky; Kgomotso Makhaola; Aida Asmelash; S'khatele Molefhabangwe; Elias Woldegabriel; Gaseboloke Mothowaeng; Talkmore Maruta; Charity Kamhukamwe; Phibeon M Mangwendeza; Molly Holmes-Pretorius; Isaac Mtoni; Modisa Motswaledi; Rosemary Musonda; Ndwapi Ndwapi; Joseph Makhema; Richard Marlink; Khumo Seipone; Tendani Gaolathe; Max Essex
Journal:  Afr J Lab Med       Date:  2012

7.  Anemia and Red Blood Cell Abnormalities in HIV-Infected and HIV-Exposed Breastfed Infants: A Secondary Analysis of the Kisumu Breastfeeding Study.

Authors:  Collins Odhiambo; Clement Zeh; Pascale Ondoa; Paul Omolo; Benta Akoth; Humphrey Lwamba; Richard Lando; John Williamson; Juliana Otieno; Rose Masaba; Paul Weidle; Timothy Thomas
Journal:  PLoS One       Date:  2015-11-03       Impact factor: 3.240

8.  Lessons from the first clinical trial of a non-licensed vaccine among Ugandan adolescents: a phase II field trial of the tuberculosis candidate vaccine, MVA85A.

Authors:  Helen McShane; Alison M Elliott; Anne Wajja; Milly Namutebi; Barbara Apule; Gloria Oduru; Samuel Kiwanuka; Mirriam Akello; Beatrice Nassanga; Joyce Kabagenyi; Juma Mpiima; Samantha Vermaak; Alison Lawrie; Iman Satti; Jaco Verweij; Stephen Cose; Jonathan Levin; Pontiano Kaleebu; Edridah Tukahebwa
Journal:  Wellcome Open Res       Date:  2018-09-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.